All 157 XBI (STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF) Holdings
There are 157 XBI holdings. Top 10 companies weight: 13.61%.
Total Market Cap: $1.70T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (157 stocks) | +9.95% | 31.39 | 16.62 | 0.44 | +21.40% | +14.06% | 0.66 | ||||||||||
101 | ORIC | Oric Pharmaceuticals Inc | 0.35% | $10.42 | $1.15B | Biotechnology | Healthcare | -10.25% | N/A | N/A | N/A | N/A | N/A | 76 | +94.72% | $20 | -10.75% | 1.45 |
102 | KURA | Kura Oncology Inc | 0.34% | $10.68 | $1.01B | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +191.85% | $31 | -10.92% | 1.06 |
103 | MNKD | Mannkind Corp | 0.34% | $3.98 | $1.26B | Biotechnology | Healthcare | -21.18% | N/A | 42.37 | 4.39 | N/A | N/A | 71 | +90.70% | $7.59 | -2.94% | 0.71 |
104 | TSHA | N/A | 0.33% | $5.58 | $1.78B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +132.97% | $13 | -22.80% | 1.42 |
105 | CDNA | Caredx Inc | 0.33% | $38.37 | $1.53B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | -14.00% | $33 | -14.62% | 1.27 |
106 | JBIO | Jade Biosciences Inc | 0.32% | $19.67 | $1.08B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +146.57% | $49 | -45.27% | 0.53 |
107 | TRAX | First Tracks Biotherapeutics Inc | 0.32% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
108 | OLMA | N/A | 0.31% | $11.35 | $1.03B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +258.59% | $41 | -15.44% | 0.72 |
109 | VOR | Vor Biopharma Inc Ordinary Shares | 0.31% | $17.45 | $980M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +117.08% | $38 | -43.35% | 1.23 |
110 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.30% | $16.05 | $976M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +131.71% | $37 | -10.96% | 1.20 |
111 | GERN | Geron Corp | 0.30% | $1.44 | $951M | Biotechnology | Healthcare | -18.28% | N/A | N/A | N/A | N/A | N/A | 66 | +136.11% | $3.40 | +1.60% | 1.16 |
112 | BCAX | Bicara Therapeutics Inc | 0.30% | $27.15 | $1.84B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +15.87% | $31 | 0.00% | 1.40 |
113 | CTMX | Cytomx Therapeutics Inc | 0.28% | $3.52 | $652M | Biotechnology | Healthcare | N/A | 24.82 | 14.20 | 0.76 | N/A | N/A | 83 | +255.11% | $13 | -9.78% | 2.01 |
114 | SION | Sionna Therapeutics Inc | 0.28% | $45.69 | $2B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 68 | +12.93% | $52 | 0.00% | 0.90 |
115 | XNCR | Xencor Inc | 0.28% | $18.81 | $1.11B | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +50.61% | $28 | -10.32% | 1.42 |
116 | AVBP | Arrivent Biopharma Inc | 0.28% | $28.22 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +54.64% | $44 | 0.00% | 0.94 |
117 | REPL | Replimune Group Inc | 0.26% | $10.51 | $801M | Biotechnology | Healthcare | +16.21% | N/A | N/A | N/A | N/A | N/A | 56 | +1.52% | $11 | -20.66% | 0.74 |
118 | RIGL | Rigel Pharmaceuticals Inc | 0.26% | $39.67 | $758M | Biotechnology | Healthcare | N/A | 6.87 | 9.01 | N/A | N/A | N/A | 65 | +36.63% | $54 | -1.37% | 1.10 |
119 | SANA | Sana Biotechnology Inc Ordinary Shares | 0.24% | $3.14 | $958M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +172.93% | $8.57 | -30.37% | 1.98 |
120 | SLDB | Solid Biosciences Inc | 0.24% | $8.45 | $947M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +107.10% | $18 | -28.67% | 1.77 |
121 | RGNX | Regenxbio Inc | 0.23% | $10.32 | $633M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +135.17% | $24 | -22.82% | 1.83 |
122 | ALT | Altimmune Inc | 0.23% | $2.81 | $374M | Biotechnology | Healthcare | -10.93% | N/A | 8.18 | 32.62 | N/A | N/A | 75 | +449.82% | $15 | -21.79% | 1.53 |
123 | ALLO | Allogene Therapeutics Inc | 0.22% | $1.77 | $465M | Biotechnology | Healthcare | -14.18% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -39.94% | N/A |
124 | DMRA | Damora Therapeutics Inc Ordinary Shares | 0.21% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
125 | IRWD | Ironwood Pharmaceuticals Inc Class A | 0.21% | $3.85 | $658M | Drug Manufacturers - Specialty & Generic | Healthcare | -12.17% | 8.62 | 12.33 | N/A | N/A | N/A | 68 | +64.94% | $6.35 | -21.91% | 1.07 |
126 | IMMX | Immix Biopharma Inc | 0.21% | $8.80 | $558M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 87 | +124.43% | $20 | 0.00% | 1.23 |
127 | VSTM | Verastem Inc | 0.19% | $5.75 | $503M | Biotechnology | Healthcare | -2.77% | N/A | N/A | N/A | N/A | N/A | 77 | +160.87% | $15 | -33.08% | 1.38 |
128 | CADL | Candel Therapeutics Inc | 0.19% | $9.57 | $706M | Biotechnology | Healthcare | N/A | N/A | 43.48 | N/A | N/A | N/A | 71 | +114.21% | $21 | 0.00% | 1.80 |
129 | OCGN | Ocugen Inc | 0.19% | $1.33 | $484M | Biotechnology | Healthcare | +8.79% | N/A | 13.07 | N/A | N/A | N/A | 78 | +759.40% | $11 | -29.62% | 1.71 |
130 | MPLT | Maplight Therapeutics Inc | 0.18% | $35.99 | $1.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +15.31% | $42 | 0.00% | 1.36 |
131 | MYGN | Myriad Genetics Inc | 0.18% | $5.92 | $596M | Diagnostics & Research | Healthcare | N/A | N/A | 54.05 | N/A | N/A | N/A | 50 | +5.57% | $6.25 | -28.67% | 1.06 |
132 | PRME | Prime Medicine Inc | 0.18% | $3.05 | $630M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +133.44% | $7.12 | 0.00% | 2.09 |
133 | FDMT | 4d Molecular Therapeutics Inc Ordinary Shares | 0.18% | $11.09 | $611M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +154.46% | $28 | -14.78% | 1.22 |
134 | SVRA | Savara Inc | 0.18% | $5.49 | $1.19B | Biotechnology | Healthcare | -2.12% | N/A | 0.41 | N/A | N/A | N/A | 81 | +99.27% | $11 | +31.62% | 1.21 |
135 | SPRY | Ars Pharmaceuticals Inc | 0.17% | $6.44 | $750M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +315.37% | $27 | -28.81% | 1.16 |
136 | ABUS | Arbutus Biopharma Corp | 0.16% | $4.41 | $898M | Biotechnology | Healthcare | N/A | 5.60 | 10.25 | N/A | N/A | N/A | 75 | +17.69% | $5.19 | +8.45% | 0.88 |
137 | CABA | Cabaletta Bio Inc Ordinary Shares | 0.14% | $2.75 | $463M | Biotechnology | Healthcare | +8.20% | N/A | N/A | N/A | N/A | N/A | 72 | +386.55% | $13 | -19.33% | 1.66 |
138 | CMPX | Compass Therapeutics Inc Ordinary Shares | 0.14% | $2.02 | $385M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +320.79% | $8.50 | -16.55% | 1.55 |
139 | CATX | Perspective Therapeutics Inc | 0.13% | $2.93 | $367M | Medical Devices | Healthcare | +89.93% | N/A | 25.71 | N/A | N/A | N/A | 76 | +342.05% | $13 | -16.72% | 1.52 |
140 | VNDA | Vanda Pharmaceuticals Inc | 0.13% | $5.32 | $352M | Biotechnology | Healthcare | N/A | N/A | 103.09 | N/A | N/A | N/A | 68 | +165.41% | $14 | -22.64% | 0.64 |
141 | EBS | Emergent Biosolutions Inc | 0.13% | $7.69 | $408M | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.08 | 0.38 | N/A | N/A | 75 | +56.05% | $12 | -34.96% | 1.88 |
142 | OVID | Ovid Therapeutics Inc | 0.12% | $2.31 | $416M | Biotechnology | Healthcare | N/A | N/A | 1.79 | N/A | N/A | N/A | 75 | +137.31% | $5.47 | -9.98% | 1.42 |
143 | MDXG | Mimedx Group Inc | 0.12% | $4.33 | $636M | Biotechnology | Healthcare | N/A | 20.55 | 19.53 | 2.88 | N/A | N/A | 80 | +52.42% | $6.60 | -18.07% | 0.73 |
144 | PRTA | Prothena Corp Plc | 0.12% | $8.67 | $447M | Biotechnology | Healthcare | -1.54% | N/A | 10.63 | N/A | N/A | N/A | N/A | +146.83% | $21 | -30.09% | 0.89 |
145 | LXEO | Lexeo Therapeutics Inc | 0.11% | $4.55 | $351M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +359.12% | $21 | 0.00% | 1.99 |
146 | ACHV | Achieve Life Sciences Inc | 0.08% | $6.24 | $174M | Biotechnology | Healthcare | -20.82% | N/A | 35.34 | N/A | N/A | N/A | N/A | N/A | N/A | -4.68% | N/A |
147 | SGMT | Sagimet Biosciences Inc Ordinary Shares Series A | 0.08% | $7.16 | $181M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +265.92% | $26 | 0.00% | 1.87 |
148 | BBOT | Bridgebio Oncology Therapeutics Inc | 0.07% | $8.42 | $674M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +200.48% | $25 | 0.00% | 1.25 |
149 | n/a | Contra Metsera Inc Common Stock | 0.07% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
150 | n/a | Contra Akero Therapeut Common Stock | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
XBI (STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF) Sector Allocation
HEALTHCARE
96.60%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%